These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21304243)

  • 21. Imiquimod in clinical practice.
    Edwards L
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
    Bernstein DI; Spruance SL; Arora SS; Schroeder JL; Meng TC
    Clin Infect Dis; 2005 Sep; 41(6):808-14. PubMed ID: 16107978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
    Blasi MA; Giammaria D; Balestrazzi E
    Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of facial plane warts with imiquimod.
    Khan Durani B; Jappe U
    Br J Dermatol; 2002 Nov; 147(5):1018. PubMed ID: 12410718
    [No Abstract]   [Full Text] [Related]  

  • 25. Five cases of recalcitrant plantar warts successfully treated with imiquimod 5% cream.
    López-Giménez MT
    Actas Dermosifiliogr; 2013 Sep; 104(7):640-2. PubMed ID: 23870849
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical treatment of nasal squamous papilloma with imiquimod cream.
    Caversaccio M; Aebi S
    J Laryngol Otol; 2003 Sep; 117(9):720-2. PubMed ID: 14561362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imiquimod for genital warts.
    Med Lett Drugs Ther; 1997 Dec; 39(1016):118-9. PubMed ID: 9422045
    [No Abstract]   [Full Text] [Related]  

  • 28. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
    Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
    Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
    Schöfer H
    Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
    Ahn CS; Huang WW
    Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imiquimod 5% cream treatment for rapidly progressive genital condyloma in a 3-year-old girl.
    Leclair E; Black A; Fleming N
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):e119-21. PubMed ID: 23158771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety studies of topical imiquimod 5% cream on normal skin exposed to ultraviolet radiation.
    Kaidbey K; Owens M; Liberda M; Smith M
    Toxicology; 2002 Sep; 178(2):175-82. PubMed ID: 12160622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large genital ulcers in a patient with Behçet's disease associated with imiquimod cream treatment for external genital warts.
    Kaya TI; Tursen U; Ikizoglu G
    Clin Exp Dermatol; 2008 Nov; 33(6):783-4. PubMed ID: 18681880
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of imiquimod 3.75% cream in the treatment of external genital warts.
    Berman B; Wolf J
    Skin Therapy Lett; 2012 Apr; 17(4):5-7. PubMed ID: 22491804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imiquimod-induced hypopigmentation following treatment of periungual verruca vulgaris.
    Edgar N; Pilkington S; Hogan DJ
    Cutis; 2018 Jun; 101(6):466-468. PubMed ID: 30063776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
    Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
    Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
    Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
    J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts.
    Wu J; Feldman R; Barry GT; Kulp J; Adams MP; Levy S
    J Clin Pharmacol; 2012 Jun; 52(6):828-36. PubMed ID: 22232733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of a novel short occlusive regimen of imiquimod for selected non-melanotic skin lesions in renal transplant patients.
    Das G; Tan B; Nicholls K
    Intern Med J; 2016 Mar; 46(3):352-5. PubMed ID: 26968597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.